Hosted by Oxford University · 🇺🇸 US · EN-UK · 16 episodes
Established thought leaders with verified media credentials.
In a series produced by the Oxford Immunology Network, Professor Paul Klenerman talks with colleagues about their recent ground-breaking publications, exploring the original scientific goals, challenges they encountered along the way, and future ambitions in the field. This series will be of interest to anyone studying or working in immunology, medical sciences, biology or related fields. NB: To Immunity and Beyond is for educational purposes only and should not be considered professional medical advice.
Oxford University hosts To Immunity and Beyond, a education show with 16 episodes published.
A conversation with Dr Rufus Daw about CellTypeAI. As single-cell datasets grow from thousands to hundreds of thousands of cells, accurate cell annotation is becoming a major bottleneck in biomedical research. In this ep
A conversation with Professor Sheena Cruickshank about the new MRC Centre of Research Excellence in Exposome Immunology. To mark World Immunology Day, we’re joined by Professor Sheena Cruickshank from the MRC Centre of R
A conversation with Professor Hashem Koohy about possibilities for use of AI in driving forward T cell research. In the first To Immunity and Beyond episode of 2026, Paul Klenerman speaks with systems biologist Hashem Ko
A conversation with Professor Andrew McMichael, Professor Tomáš Hanke, and Dr Fon Acho about current priorities in HIV treatment and prevention. In this episode of To Immunity and Beyond, we talk to HIV immunologist Prof
A conversation with Philip Goulder about the recent article ‘Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission’. In this episode of To Immunity and Beyond,
A conversation with Fadi Issa about his recent article on regulatory T cell therapy in kidney transplants. In this episode of To Immunity and Beyond, Paul Klenerman talks with surgeon and immunologist Fadi Issa about pio
A conversation with Miles Carroll and Oliver Meek about their recent Ebola virus persistence review article. In this episode, Oliver Meek and Miles Carroll discuss their recent review on Ebola virus (EBOV) persistence, s
A conversation with Zakiya Leeming and Rachel Hindmarsh about the Thanks for the Memories project and a new opera. The Thanks for the Memories public engagement programme is about to premier a new opera, ‘Dangerous Matte
A conversation with Zakiya Leeming and Rachel Hindmarsh about the Thanks for the Memories project and a new opera. The Thanks for the Memories public engagement programme is about to premier a new opera, ‘Dangerous Matte
A conversation with Ben Fairfax about the recent article: CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade. This episode discusses Milotay, G., Little
A conversation with Yang Hu about his recent article: Self-interactive learning: Fusion and evolution of multi-scale histomorphology features for molecular traits prediction in computational pathology. This episode discu
Research on human cells in space may uncover the hidden mechanisms behind ageing. Exciting developments are underway at the Space Innovation Lab at the University of Oxford! The launch of human tissue samples to the Inte
Dr Kirsty McHugh and Dr Carolyn Nielsen discuss a recent Cell article: ‘Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype’. This ep
Dr. Barbara Kronsteiner-Dobramysl discusses a recent Metabolism article: ‘Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection’. This episode discusses the fol
Professor Omer Dusk discusses a bioRxiv pre-print: ‘Optimising CAR-T cell sensitivity by engineering matched extracellular sizes between CAR/antigen and CD2/CD58 adhesion complexes’. This episode discusses the following
Professor Omer Dusk discusses a bioRxiv pre-print: ‘Optimising CAR-T cell sensitivity by engineering matched extracellular sizes between CAR/antigen and CD2/CD58 adhesion complexes’. This episode discusses the following
Professor Quentin Sattentau discusses research published in 'Nature Communications' on the role of enzyme ADAM10 in mediating clearance of apoptotic T cells by macrophages. This episode discusses Drexhage, LZ, Zhang, S,
Professor Astrid Iversen discusses research published in Nature, using historic genome data to investigate the emergence of genetic risk for multiple sclerosis in Northern Europe. This episode discusses Barrie, W, Yang,
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To Immunity and Beyond has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their education audience.
To Immunity and Beyond is hosted by Oxford University. The show is categorised under education and has published 16 episodes.
To Immunity and Beyond has published 16 episodes.
To Immunity and Beyond regularly covers education. It sits in the education category.
To Immunity and Beyond is accessible for guests with genuine education expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
To Immunity and Beyond hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of To Immunity and Beyond average 30 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates To Immunity and Beyond's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 9 days ago.
